122 related articles for article (PubMed ID: 311392)
1. [Normal human lymphocyte mediated cytotoxicity against an established cell line (KU-2) derived from human renal cell carcinoma: role to T & B cells as effector (author's transl)].
Jistukawa S
Nihon Hinyokika Gakkai Zasshi; 1978 Dec; 69(12):1623-38. PubMed ID: 311392
[No Abstract] [Full Text] [Related]
2. [Studies on the immune status of patients with renal cell carcinoma (author's transl)].
Moriyama M; Kubota Y; Shuin T; Nishimura R; Takai S
Nihon Hinyokika Gakkai Zasshi; 1980 Dec; 71(12):1446-55. PubMed ID: 7230561
[No Abstract] [Full Text] [Related]
3. [The significance of lymphocytic infiltration in urologic tumors: studies of distributions of B and T-lymphocytes and its subsets, and functional analysis of the infiltrating lymphocytes (author's transl)].
Akaza H
Nihon Hinyokika Gakkai Zasshi; 1981 Jan; 72(1):86-97. PubMed ID: 6974272
[No Abstract] [Full Text] [Related]
4. Transitional cell and renal carcinoma: cell-mediated immunity as determined by the lymphocyte titration technique.
Hakala TR
Natl Cancer Inst Monogr; 1978 Dec; (49):151-2. PubMed ID: 571043
[TBL] [Abstract][Full Text] [Related]
5. Specificity of cellular immunity to renal cell carcinoma.
Daly JJ; Prout GR; Ahl CA; Lin JC
J Urol; 1974 Apr; 111(4):448-52. PubMed ID: 4819368
[No Abstract] [Full Text] [Related]
6. [The function of different lymphocyte groups and methods for their separation (author's transl)].
Eckert R
Arch Geschwulstforsch; 1975; 45(6):594-605. PubMed ID: 57763
[TBL] [Abstract][Full Text] [Related]
7. Cell-mediated immunity in patients with renal adenocarcinoma.
Bichler KH; Ax W; Tautz C
Eur Urol; 1975; 1(5):231-4. PubMed ID: 61119
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte subpopulations in gastric cancer. Preoperative evaluation.
Sanz ML; Crisci CD; Hernández JL; Subirá ML; Voltas J; Zornoza G; Oehling A
Allergol Immunopathol (Madr); 1978; 6(5):415-22. PubMed ID: 311148
[No Abstract] [Full Text] [Related]
9. Cellular immunity in nasopharyngeal carcinoma. III. Lymphocyte subpopulations and lymphocyte response to phytohemagglutinin.
Hsu MM; Wang KR; Lynn TC; Hsieh T; Tu SM
Taiwan Yi Xue Hui Za Zhi; 1978 Jul; 77(7):549-55. PubMed ID: 308994
[No Abstract] [Full Text] [Related]
10. Lymphocyte-mediated cytotoxicity in patients with renal and transitional cell carcinoma receiving BCG.
Lange PH
Natl Cancer Inst Monogr; 1978 Dec; (49):343-5. PubMed ID: 748791
[TBL] [Abstract][Full Text] [Related]
11. Cell-mediated immunity to tumor antigens in patients with renal cell carcinoma.
Cummings KB; Peter JB; Kaufman JJ
J Urol; 1973 Jul; 110(1):31-5. PubMed ID: 4713354
[No Abstract] [Full Text] [Related]
12. [Establishment of a new cell line (NRC-12) derived from a human renal cell carcinoma and its characteristics (author's transl)].
Komatsubara S
Nihon Hinyokika Gakkai Zasshi; 1978 Dec; 69(12):1535-42. PubMed ID: 745323
[No Abstract] [Full Text] [Related]
13. [Cytotoxicity of peripheral lymphocytes from patients with hepatoma on human hepatoma cell line. IV. Electron microscopic studies on the in vitro interaction between human lymphocytes and human cultured hepatoma cells (author's transl)].
Munakata Y; Oda M; Morizane T; Watanabe T; Tsuchimoto K; Tsuchiya M
Nihon Shokakibyo Gakkai Zasshi; 1980 Mar; 77(3):395-409. PubMed ID: 6247525
[No Abstract] [Full Text] [Related]
14. Immune cytolysis of human renal carcinoma mediated by xenogeneic immune ribonucleic acid.
Brower PA; Dekernion JB; Ramming KP
J Urol; 1976 Mar; 115(3):243-5. PubMed ID: 1255883
[TBL] [Abstract][Full Text] [Related]
15. [Comparative study of the activating effects of recombinant human interleukin 2 and interferon-gamma on cell-mediated cytotoxicity against renal cell carcinoma in vitro].
Marumo K; Ueno M; Baba S; Muraki J; Deguchi N; Tazaki H
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1825-9. PubMed ID: 3109327
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte antibody interaction in cytotoxicity against human transitional cell carcinoma.
Hakala TR; Lange PH; Castro AE; Elliott AY; Fraley EE
J Urol; 1975 May; 113(5):663-7. PubMed ID: 1168732
[TBL] [Abstract][Full Text] [Related]
17. [Study on transcatheter embolization for renal carcinoma. 2nd Report--host immune response after transcatheter embolization (author's transl)].
Nakano H
Nihon Hinyokika Gakkai Zasshi; 1980 Aug; 71(8):913-26. PubMed ID: 6159494
[No Abstract] [Full Text] [Related]
18. General immunocompetence and tumour-directed, cell-mediated hypersensitivity in vitro in patients with renal carcinoma.
Kjaer M; Thomsen M
Acta Pathol Microbiol Scand C; 1976 Oct; 84C(5):403-13. PubMed ID: 136864
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte mediated natural cytotoxicity in neoplasia.
Menon M; Stefani SS
Oncology; 1978; 35(2):63-7. PubMed ID: 306592
[TBL] [Abstract][Full Text] [Related]
20. [Assessment of the immunodeficiency of patients with lymphomata in relapse and in clinical remission (author's transl)].
Ruibal Ares B; Sasiain M; Brezavscek DM; Suarez A; Bachmann AE
Sangre (Barc); 1978; 23(5):535-43. PubMed ID: 311077
[No Abstract] [Full Text] [Related]
[Next] [New Search]
